Researchers working on the Human Functional Genomics Project have begun to unravel genetic relationships and variations in human immune response.
The updated repository includes 265 drugs, 1,074 cell lines, as well as associated whole-exome sequencing and gene expression data among other datasets.
A high risk score was associated with worse memory, smaller hippocampi, and cognitive decline, and could be used to detect disease prior to the onset of symptoms.
The Food Allergy Science Initiative seeks to supply the basic scientific research needed to spur future development of diagnostics and therapeutics.
The analysis also indicates that vascular and smooth muscle tissues contribute to migraine pathophysiology.
Researchers identified a mutational signature that's more common in urothelial tumors with non-silent somatic mutations in the nucleotide excision repair gene ERCC2.
A pair of Massachusetts General Hospital researchers has developed an approach to sift through blood samples for tumor cells, Stat News reports.
Two Boston-based researchers shared methods for detecting circulating nucleic acid biomarkers for potential use in cancer diagnosis and monitoring.
Starting from sequence and SNP data for hundreds of thousands of unselected individuals, researchers estimated penetrance for variants in the prion protein gene.
Repeat molecular analysis of a patient's cancer helped clinicians guide targeted therapies as drug resistance emerged and ebbed.
A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.
NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.
The New York Times reports on how environmental DNA sampling could monitor endangered species.
In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.